The clinical trials for Modafinil, a nootropic, started in the year 1986 in France. The results proved to be excellent and it was officially registered in 1992 and was first prescribed in 1994 in France. Later, it was prescribed in the USA in the year 1998 with FDA approval for treating narcolepsy. Five years later it was approved for treating obstructive sleep apnea. Its wakefulness-promoting properties attracted students, entrepreneurs, athletes and the military people. The users of Modafinil were impressed with its effects and started to promote the drug in the period from 2011 – 2013.